Web Analytics

Theodore M. Sullivan quoted in article "FDA Moves to Help CMS With Device Coverage Decisions"

Media Mention
Bloomberg BNA

Below is an excerpt:

The updates the draft guidance makes to the FDA's categorization process simplifies what was a complicated procedure, Theodore Sullivan, a Washington-based attorney at Quarles & Brady LLP, told Bloomberg BNA May 31.

Essentially, the device categorization process comes down to whether the product is safe and effective, Sullivan said. The draft guidance allows industry to focus on this question, instead of worrying about several subcategories that existed under the previous categorization process, he said.

Originally published in Bloomberg BNA, June 1, 2016


Related People

Related Capabilities

Follow Quarles

Subscribe Media Contact
Back to Main Content

We use cookies to provide you with the best user experience on our website and to analyze statistics related to our website. To understand more about how we use cookies, or for instructions to change your preference and browser settings, please see our Privacy Notice. Please note that if you choose to reject cookies, doing so may impair some of our website's functionality.